Latest California Healthline Stories
Why Are More Older People Dying After Falls?
Some researchers suspect that rising prescription drug use may explain a disturbing trend.
¿Por qué mueren más personas mayores después de sufrir caídas?
En 2023, el año más reciente con datos disponibles de los Centros para el Control y Prevención de Enfermedades (CDC), más de 41.000 personas mayores de 65 años murieron por caídas.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
KFF Health News' 'What the Health?': Countdown to Government Shutdown
With less than three weeks before the deadline to pass legislation to keep the federal government running, lawmakers are still far apart on a strategy. Democrats hope Republicans will agree to extend expanded tax credits for the Affordable Care Act as part of a compromise, but so far Republicans are not negotiating. Meanwhile, HHS Secretary Robert F. Kennedy Jr. released his long-awaited “Make America Healthy Again” report, with few specific action items. Anna Edney of Bloomberg News, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Breaking Down Why Medicare Part D Premiums Are Likely To Go Up
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
KFF Health News' 'What the Health?': Kennedy Cancels Vaccine Funding
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
An Arm and a Leg: The Prescription Drug Playbook, Part II
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
An Arm and a Leg: The Prescription Drug Playbook, Part I
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
A new drug is helping families who’ve spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress — and a broader understanding of obesity — is now under threat as the government dismantles the pipeline for promising new research.